FMO10P

Across TCGA pan-cancer cohorts, FMO10P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated FMO10P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher FMO10P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FMO10P expression acts as an unfavorable survival marker.

BRCA, STAD, and LIHC are the cancer types where FMO10P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.411	0.588	<.001	96	view →
STAD	OS	Tertile	II,III,IV	0.186	0.603	<.001	36	view →
LIHC	OS	Tertile	All	0.443	0.705	<.001	21	view →
KIRC	DFS	Tertile	All	0.376	0.650	.005	12	view →
MESO	OS	Tertile	All	0.169	0.556	.043	9	view →
COAD	OS	Tertile	All	0.210	0.799	.014	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

FMO10P–BRCA (OS)

Open the BRCA breakdown →